Transcription factor IRF4 determines germinal center formation through follicular T-helper cell differentiation + germinal center (GC) B cells to induce antibody maturation. Herein, we identify the transcription factor IRF4 as a T-cell intrinsic precondition for T FH cell differentiation and GC formation. After immunization with protein or infection with the protozoon Leishmania major, draining lymph nodes (LNs) of IFN-regulatory factor-4 (Irf4 T FH cell differentiation was not rescued by close neighborhood to transferred WT T FH cells. Together with its known B lineage-specific roles during plasma cell maturation and class switch, our study places IRF4 in the center of antibody production toward Tcell-dependent antigens.
interleukin-21 | inducible costimulator | CXC-chemokine receptor 5 | apoptosis A part from Th1 and Th2, the family of Th subsets now includes Th17 and Th9 (1) . In addition, follicular T-helper (T FH ) cells are defined based on their location within germinal center cells (GCs) of lymphoid organs (2, 3) . Here, these cells produce cytokines that normally define other subsets, such as the Th2 product IL-4 (4, 5) or the Th17 product IL-21 (6) , which is involved in GC B-cell generation (7) (8) (9) (10) . T FH cell propagation is supported by the transcription factor B-cell lymphoma (BCL)-6 and suppressed by Blimp1 (11) (12) (13) . Further markers used to define T FH cells include inducible costimulator (ICOS), programmed death-1 (PD-1), and CXC-chemokine receptor 5 (CXCR5), which mediate their migration into GCs (2, (14) (15) (16) .
The IFN-regulatory factor (IRF) family of transcription factors includes nine members in mammals that bind to related target-gene sequences (17) . We and others have described important roles of IRFs during Th cell differentiation. In particular, IRF1 is decisive for Th1 cell generation because it is ubiquitously expressed and redundantly addresses many genes with independent Th1-supporting function (17) (18) (19) . In contrast, IRF4 controls Th2 and Th17 cell differentiation (20) (21) (22) (23) , with ensuing total resistance of Irf4 −/− mice in a Th17-dependent mouse model of multiple sclerosis (24) . In addition, regulatory T-cell (Treg)-specific IRF4 deficiency or lack of IRF4 binding protein lead to a generalized autoimmune syndrome (25, 26) . Finally, we reported on the role of IRF4 during Th9 differentiation (27) .
Remarkably, IRF4 is also a B-cell intrinsic prerequisite for class switch and plasma cell maturation (28, 29) .
Given these pleiotropic activities of IRF4 on B and T cells, we wondered whether IRF4 also contributes to the interaction of T FH and GC B cells. Herein, we use chronic leishmaniasis, a model infection with prominent T-and B-cell interactions (30) to prove a decisive T-cell intrinsic role of IRF4 for murine T FH cell development.
Results

Irf4
−/− Mice Fail to Generate GCs. To study the development of T FH cells in vivo, we infected Irf4 −/− mice and Irf4-competent control mice with Leishmania major (30) . Two weeks later, draining popliteal lymph nodes (LNs) were analyzed ( Figs. 1 and 2 ). By immunohistology, prominent GC formation was observed in WT and Irf4
+/− LNs, including presence of GL7 + GC cells (Fig 1A) . In contrast, GCs were totally absent in Irf4 −/− LNs and few GL7 + cells were dispersed throughout the LN. However, Irf4 −/− LNs did contain normal B and CD4 T-cell areas (Fig. 1A , Bottom Right). We confirmed the lack of GCs in Irf4 −/− mice that were immunized with the myelin oligodendrocyte glycoprotein (MOG) peptide instead of L. major infection (Fig. S1 ) and in Peyer's patches (PP) from naive mice (Fig. 3A) .
A strong reduction in GC B cells coexpressing the markers GL7 and CD95 (31, 32) was verified by flow-cytometry of single LN cell suspensions from L. major infected Irf4 −/− mice (Fig. 1B , note the compiled data of three different experiments). Again, the finding was reproduced in PP from naive mice (Fig. 3B) . In control FACS-stainings, GL7 was only weakly expressed on WT and Irf4 −/− CD4 + cells. Thus, Irf4 −/− mice form the architecture of normal LNs, but lack GC formation. Furthermore, the ICOS ligand (ICOSL) molecule was strongly up-regulated on Irf4 −/− B compared with WT B cells (Fig. 1C) Fig. 2A) . Both findings were confirmed in PP of naive mice (Fig. 3C) . As for PD-1, its expression was comparable in CD4 + cells of infected Irf4 −/− and Irf4 +/− mice ( Fig. 2A) , but was also reduced in Irf4 −/− CD4 + cells of naive PP (Fig. 3C) . Furthermore, amounts of BCL-6 protein, a central molecule for T FH cell function (11) (12) (13) , were considerably lower in Irf4 −/− than in Irf4 +/− CD4 + cells (Fig. 2B ). An even stronger defect was noted with respect to IL-21 production ( Fig. 2C) (Fig. S2B ). Mechanical dissociation and reanalysis confirmed lower CXCR5 staining on T cells. Thus, outgating of B-T conjugates did not remove any T FH cells with particularly strong CXCR5 staining, and was routinely used during data acquisition (with the exception of Figs. S2 and S3). We detected B-T conjugates not only in the Leishmania model, but also in PP of naive mice (Figs. S2 and S3) or after MOG immunization. Although CXCR5 clearly remains a marker of T FH cells, these T-B conjugates suggest critical care during its staining on T cells.
When we now compared CXCR5 expression on Irf4 −/− and WT cells, we found that CXCR5 staining was totally absent in Irf4 −/− CD4 + cells (Fig. 2D) , confirming their lack of T FH cells. Importantly, this conclusion required exclusion of B-T conjugates from the analysis ( To rule out a defect of Irf4 −/− T cells in their receptor-triggered antigenic response as a trivial reason for T FH cell deficiency, we restimulated LN cells of infected mice in vitro. In response to Leishmania antigens, Irf4
−/− and Irf4 +/− control CD4 + cells secreted the precursor T-cell product IL-2 into their supernatants at the same order of magnitude (Fig. S4A) . Similarly, the frequency of intracellularly stained IL-2-producing CD4 + cells was similar between the two genotypes ( Fig S4B) .
Lack of Irf4 −/− T FH Cells Is Not Caused by a Cell Viability Problem.
Previously, we reported on apoptotic death of Irf4 −/− draining LN cells after about 6 wk of leishmaniasis (34) . We therefore aimed to exclude that a cell viability problem hindered GC formation earlier after infection. In naive young Irf4 −/− and Irf4
mice, the size of popliteal LNs was comparable (about 1 × 10 6 cells). Furthermore, the increase in LN size and histological appearance 2 wk after infection were similar (Fig. 4 A and B) , but Irf4 −/− and Irf4 +/− CD4 + LN T cells were comparably able to secrete IL-2 ( Fig. S4 ) and to proliferate in response to phorbol 12-myristate 13-acetate (PMA) and ionomycin (Fig. 4C) . These data confirm functional integrity of Irf4 −/− LN CD4 + T cells at the time point when the lack of GC formation was noted. In contrast, Irf4 −/− LNs had almost totally disappeared 6 wk after infection (Fig. 4A) , and severe damage in LN cell morphology was already visible 4 wk after infection (Fig. 4B) . Cell death did not occur in other LNs of infected Irf4 −/− mice. The divergence in LN cell viability of WT and Irf4 −/− mice 6 but not 2 wk after infection is underscored by the compiled statistical significance of all mice tested (Fig. 4A ). In conclusion, lack of Irf4 −/− GC formation cannot be explained by disturbed cell viability. −/− mice were reconstituted intraperitonially with purified CD45 (Ly5.1 + ) congenic CD4 + cells from naive mice at the start of infection. Two weeks later-that is, at the maximum of GC formation in WT mice-transferred WT CD4 + T cells had perfectly rescued the appearance of GCs and GL7 + Irf4 −/− B cells (Fig. 5A) . Furthermore, the WT cells tended to accumulate close to the GC areas, but endogenous CD4 + T cells mostly remained outside of them. By flow cytometry, WT CD4 + T-cell transfer totally rescued the generation of Irf4 −/− GL7 + CD95 + GC B cells (Fig. 5B ) and the compensatory up-regulation of ICOSL on Irf4 −/− B cells was almost reverted (Fig. 5C ). Because WT CD4
+ cells can induce GC formation and GC B-cell differentiation in Irf4 −/− mice, their T FH defect is caused by an intrinsic T-but not B-cell defect. Accordingly, B-cell-specific deficiency in IRF4 leads to disturbed plasma cell differentiation, but no change in GC formation (28) . However, this plasma cell defect precludes demonstration of effects of the transferred WT CD4 + T cells on antibody formation in our mice.
Rescue of LN Cell Survival by WT CD4
+ T Cells. Like GC formation, LN cell survival 6 wk after infection was rescued to a great extent by transferred CD4 + cells and normal histological morphology was regained (Fig. 6 A and B) . Most of the surviving LN cells did not express the Ly5.1 marker of the transferred WT cells (Fig. 6C) 
CXCR5
− CD4 + T cells rescued endogenous LN cell viability, as seen from cell numbers and normal proliferative behavior (Fig. 6 D and E) . Transferred T FH cells also rescued a resistant phenotype during leishmaniasis (Fig. S5D) , and ICOS − CXCR5 − CD4 + T cells did not. Taken together, these data suggest a link between the T FH cell defect and cell death in the draining Irf4 −/− LNs during chronic leishmaniasis.
Role of IL-21. Next, we considered lack of a particular T FH cell product as primary cause of LN cell death and missing Irf4 −/− GC formation. An important candidate was IL-21, which is induced within T FH cells via the ICOS-c-Maf axis (9, 36) and is required for GC B-cell differentiation (7-10). We considered IL-21 as well, because expression of ICOS and IL-21 by Irf4 −/− cells is disturbed (Fig. 2 and ref. 21) , and because IRF4 binds the ICOS promoter (25) and mediates cell responses to IL-21 together with STAT3 (37) . To test for a role of IL-21, we compared the effects of adoptively transferred purified Il21 −/− and WT CD4 + T cells on GC formation and LN cell survival in Irf4
−/− mice 2 wk after infection (Fig. 7) . Although transferred WT cells again perfectly rescued the appearance of GCs and GL7 + cells (Fig. 7A) (Fig. 6) , part of the mice was ana- −/− LN cell survival were weaker, they still were demonstrable with high significance compared with Irf4 −/− mice without cell transfer.
Discussion
In the past, IRF4 has been characterized as an important transcription factor for differentiation of Th2, Th9, and Th17 cells. In addition, aspects of Treg cell function entirely depend on IRF4 (20) (21) (22) (23) (25) (26) (27) . In the B-cell lineage, IRF4 is important for plasma cell differentiation and isotype switching (28, 29) . Our results link these previous findings in B and T cells and show an additional important role of IRF4 for development of T FH cells, which are mainly responsible for the intricate organization of T-B interactions and antibody maturation in vivo. For our analysis, we used infection of mice with L. major, a model characterized by strong B-and T-cell interactions and LN hyperplasia (30) . When analyzing LNs of WT and Irf4 −/− mice at the height of GC formation in WT mice, a striking defect of Irf4 −/− mice became apparent: despite normal structure of Band T-cell areas, their LNs totally lacked GC formation and differentiation of GC B cells. These findings were confirmed in PPs of naive mice and after immunization with a peptide instead of L. major infection. In parallel, LN CD4 + T cells expressed strongly reduced amounts of the T FH cell-related (2, 11-13, 15, 16) molecules ICOS, IL-21, and BCL-6.
A remarkable result was obtained with respect to the T FH marker CXCR5 in that LN cell suspensions contained conjugates of adherent B-T cells, which conferred the risk for misinterpreting FACS data on CXCR5-expression in CD4 + T cells, (20, 26, 27) . A direct causal link of parasite burden and LN cell survival is not likely, given that draining LNs of mice from other highly susceptible strains behave totally differently.
Of note, adoptive transfer of WT CD4 + cells rescued not only LN cell survival, but also appearance of GCs and GC B cells with normalized expression of ICOSL in accordance with the feedback-loop between ICOS and ICOSL (33) . These findings underline that the Irf4 −/− T FH cell defect is T-cell intrinsic and support a report on normal GC formation in mice with a B-cellspecific defect of IRF4 (28) . Transfer of Il-21 −/− CD4 + T cells proved a central role for IL-21 during the rescue of GC formation. In contrast, IL-21 was necessary but not sufficient for protection from LN cell death, because Il-21 −/− CD4 + T cells supported cell survival only partially. LN cell survival during a chronic immune response is of central importance and may be regulated by independent effector molecules, such as IL-4, which is produced locally by T FH cells (4, 5) and which (like IL-21) cannot be produced by Irf4 −/− Th cells (22, 23) . As for the mechanism how IRF4 affects T FH cell differentiation, we consider an important role to their key transcription factor BCL-6 (11-13), because its amounts are strongly reduced in Irf4 −/− CD4 + T cells. Apparently, this BCL-6-enhancing function of IRF4 is cell-type-specific, because IRF4 suppresses BCL-6 transcription in B cells (38) . In addition, IRF4 physically binds to BCL-6 (39) and lack of this interaction may explain why Irf4 −/− Th cells are totally unable to differentiate into T FH cells, although they still express some BCL-6. Possibly, the T FH inducing capacity of BCL-6 requires its interaction with IRF4.
In conclusion, we demonstrate a decisive role of IRF4 for development of T FH cells and, as a consequence, formation of GCs, differentiation of GC B cells, and survival of LN cells during an immune response. Together with the earlier findings that IRF4 also targets class-switching and terminal plasma cell differentiation, our study places IRF4 in the center of B-T cooperation during the formation of an adaptive immune response.
Materials and Methods
Mice and L. major Infection or Immunization. WT C57BL/6 mice, purchased from Charles River, CD45.1 congenic, Il-21 −/− (from National Institutes of Health Mutant Mouse Regional Resource Centers), and Irf4 +/− and Irf4 −/− mice (bred in our own animal facilities) were used at 6-10 wk of age. Infection with promastigotes of the L. major strain MHOM/IL/81/FEBNI into the footpad, determination of lesion development or parasite burden, and leishmania-specific in vitro cell restimulation were performed as previously described (18, 34) . Popliteal LNs or spleens were removed at the indicated timepoints for histology, qPCR, and FACS analysis, as detailed in SI Materials and Methods. Total IgM levels were measured in a sandwich ELISA by coating with goat anti-mouse IgM followed by application of mouse sera and detection with AP-conjugated goat anti-mouse IgM (both reagents from Chemicon/Millipore). Immunization with MOG peptide and adjuvant was performed as previously described (20) . All animal experiments were approved by "Regierungspräsidium Gießen" [permission number: V54-19c20-15(1) MR 20/ 6 Nr47/2009], the local institutional committee.
Statistics. For statistical analysis, we used an unpaired t test with Welch's correction.
